These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6975658

  • 1. Cisplatin combination chemotherapy in non-oat cell carcinoma of the lung.
    Vincent RG, Lane WW, Raza S, Madajewicz S.
    Cancer Treat Rep; 1982 Jan; 66(1):197-8. PubMed ID: 6975658
    [No Abstract] [Full Text] [Related]

  • 2. Diamminodichloroplatinum combination chemotherapy in non-oat cell carcinoma of the lung.
    Vincent RG, Lane WW, Raza S, Madajewicz S.
    J Surg Oncol; 1982 Jan; 19(1):48-51. PubMed ID: 7035745
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
    Vogelzang NJ, Bonomi PD, Rossof AH, Wolter J.
    Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
    [No Abstract] [Full Text] [Related]

  • 7. Small cell bronchogenic carcinoma. A prolonged remission following chemotherapy.
    Cohen MH.
    JAMA; 1977 Jun 06; 237(23):2528. PubMed ID: 576972
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
    Vogl SE, Wollner D, Kaplan BH, Berenzweig M.
    Cancer Treat Rep; 1980 Jun 06; 64(4-5):717-9. PubMed ID: 6159081
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. "CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.
    Lad T, Sarma PR, Diekamp U, Tichler T, Chawla M, Krauss S, Zawila P, Nelson R.
    Cancer Clin Trials; 1979 Jun 06; 2(4):321-6. PubMed ID: 394868
    [Abstract] [Full Text] [Related]

  • 12. Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.
    Green MR.
    J Clin Oncol; 2008 Jul 01; 26(19):3112-3. PubMed ID: 18591551
    [No Abstract] [Full Text] [Related]

  • 13. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].
    Salvati F, Pallotta G, Antilli A, Nunziati F, De Marinis F, Lucchesi M.
    G Ital Chemioter; 1984 Jul 01; 31(1-2):185-9. PubMed ID: 6088341
    [No Abstract] [Full Text] [Related]

  • 14. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
    Evans WK, Feld R, DeBoer G, Osoba D, Curtis JE, Baker MA, Myers RE, Quirt IC, Pritchard KI, Brown TC, Kutas GJ, Blackstein ME, Ottema B, Millband L.
    Cancer Treat Rep; 1981 Jul 01; 65(11-12):947-54. PubMed ID: 7028256
    [Abstract] [Full Text] [Related]

  • 15. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J, Saiz García F.
    Med Clin (Barc); 1981 Jul 01; 79(9):403-6. PubMed ID: 6296560
    [No Abstract] [Full Text] [Related]

  • 16. Phase II study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma.
    Pisoni MB, Libretti A, Piazza E, Vago G, Scapaticci R, Bianchi C, Tomirotti M, Scanni A, Calzavara MP, Cassani L, Scarpazza G, Marsoni S, Morasca L.
    Cancer Treat Rep; 1981 Jul 01; 65(7-8):731-2. PubMed ID: 6788372
    [No Abstract] [Full Text] [Related]

  • 17. Combination chemotherapy for extracranial metastases of a primary malignant cerebral neoplasm.
    Oster MW.
    Cancer Treat Rep; 1979 Aug 01; 63(8):1417-8. PubMed ID: 476715
    [Abstract] [Full Text] [Related]

  • 18. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
    Athanassiades P, Lagoudis M, Kostis E.
    J Chemother; 1989 Jul 01; 1(4 Suppl):1205-6. PubMed ID: 16312835
    [No Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
    Denes AE, Presant CA, Bartolucci A.
    Cancer Treat Rep; 1982 Jan 01; 66(1):199-200. PubMed ID: 7053258
    [No Abstract] [Full Text] [Related]

  • 20. Cisplatin-induced autonomic neuropathy.
    Rosenfeld CS, Broder LE.
    Cancer Treat Rep; 1984 Apr 01; 68(4):659-60. PubMed ID: 6538810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.